1 Gross WL, Csernok E, Flesch BK. ‘‘Classic’’ anti-neutrophil
cytoplasmic autoantibodies (cANCA), ‘‘Wegener’s autoantigen’’
and their immunopathogenic role in Wegener’s granulomatosis.
J Autoimmun 1993; 6: 171–184.
2 Falk RJ, Terrell RS, Charles LA, et al. Anti-neutrophil cytoplasmic
autoantibodies induce neutrophils to degranulate and produce
oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:
4115–4119.
3 Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic
autoantibodies specific for myeloperoxidase cause glomerulonephritis
and vasculitis in mice. J Clin Invest 2002; 110: 955–963.
4 Brouwer E, Huitema MG, Mulder AH, et al. Neutrophil activation
in vitro and in vivo in Wegener’s granulomatosis. Kidney Int 1994;
45: 1120–1131.
5 Cordier JF, Valeyre D, Guillevin L, et al. Pulmonary Wegener’s
granulomatosis. A clinical and imaging study of 77 cases. Chest
1990; 97: 906–912.
6 Schnabel A, Reuter M, Csernok E, et al. Subclinical alveolar
bleeding in pulmonary vasculitides: correlation with indices of
disease activity. Eur Respir J 1999; 14: 118–124.
7 Newall C, Schinke S, Savage CO, et al. Impairment of lung function,
health status and functional capacity in patients with ANCAassociated
vasculitis. Rheumatology (Oxford) 2005; 44: 623–628.
8 Schnabel A, Csernok E, Braun J, et al. Activation of neutrophils,
eosinophils, and lymphocytes in the lower respiratory tract in
Wegener’s granulomatosis. Am J Respir Crit Care Med 2000; 161:
399–405.
9 Hoffman GS, Sechler JM, Gallin JI, et al. Bronchoalveolar lavage
analysis in Wegener’s granulomatosis. A method to study disease
pathogenesis. Am Rev Respir Dis 1991; 143: 401–407.
10 Amitani R, Wilson R, Rutman A, et al. Effects of human neutrophil
elastase and Pseudomonas aeruginosa proteinases on human
respiratory epithelium. Am J Respir Cell Mol Biol 1991; 4: 26–32.
11 Guillevin L, Cordier JF, Lhote F, et al. A prospective, multicenter,
randomized trial comparing steroids and pulse cyclophosphamide
versus steroids and oral cyclophosphamide in the treatment of
generalized Wegener’s granulomatosis. Arthritis Rheum 1997; 40:
2187–2198.
12 Wagner JG, Roth RA. Neutrophil migration mechanisms, with an
emphasis on the pulmonary vasculature. Pharmacol Rev 2000; 52:
349–374.
13 Strieter RM, Gomperts BN, Keane MP. The role of CXC
chemokines in pulmonary fibrosis. J Clin Invest 2007; 117: 549–556.
14 Perkins GD, Nathani N, McAuley DF, et al. In vitro and in vivo
effects of salbutamol on neutrophil function in acute lung injury.
Thorax 2007; 62: 36–42.
15 Torheim EA, Yndestad A, Bjerkeli V, et al. Increased expression
of chemokines in patients with Wegener’s granulomatosis –
modulating effects of methylprednisolone in vitro. Clin Exp
Immunol 2005; 140: 376–383.
16 Ohta N, Fukase S, Aoyagi M. Serum levels of soluble adhesion
molecules ICAM-1, VCAM-1 and E-selectin in patients with
Wegener’s granulomatosis. Auris Nasus Larynx 2001; 28: 311–314.
17 Cockwell P, Brooks CJ, Adu D, et al. Interleukin-8: a pathogenetic
role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Kidney Int 1999; 55: 852–863.
18 Mukae H, Matsumoto N, Ashitani J, et al. Neutrophil-related
cytokines and neutrophil products in bronchoalveolar lavage fluid
of a patient with ANCA negative Wegener’s granulomatosis. Eur
Respir J 1996; 9: 1950–1954.
19 Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic
vasculitides. Proposal of an international consensus conference.
Arthritis Rheum 1994; 37: 187–192.
20 Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis
Activity Score (BVAS) in systemic necrotizing vasculitis. QJM
1994; 87: 671–678.
21 Perkins GD, Chatterjie S, McAuley DF, et al. Role of nonbronchoscopic
lavage for investigating alveolar inflammation and permeability
in acute respiratory distress syndrome. Crit Care Med 2006;
34: 57–64.
22 Giudicelli J, Philip PJ, Delque P, et al. A single-step centrifugation
method for separation of granulocytes and mononuclear cells from
blood using discontinuous density gradient of Percoll. J Immunol
Methods 1982; 54: 43–46.
23 Heit B, Kubes P. Measuring chemotaxis and chemokinesis: the
under-agarose cell migration assay. Sci STKE 2003; 2003: L5.
24 Schnabel A, Reuter M, Gloeckner K, et al. Bronchoalveolar lavage
cell profiles in Wegener’s granulomatosis. Respir Med 1999; 93:
498–506.
25 Schnabel A, Csernok E, Braun J, et al. Inflammatory cells and
cellular activation in the lower respiratory tract in Churg-Strauss
syndrome. Thorax 1999; 54: 771–778.
26 Jonker ND, Peters AM, Gaskin G, et al. A retrospective study of
radiolabeled granulocyte kinetics in patients with systemic
vasculitis. J Nucl Med 1992; 33: 491–497.
27 Cantin AM, North SL, Fells GA, et al. Oxidant-mediated epithelial
cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987; 79:
1665–1673.
28 Cailes JB, O’Connor C, Pantelidis P, et al. Neutrophil activation in
fibrosing alveolitis: a comparison of lone cryptogenic fibrosing
alveolitis and systemic sclerosis. Eur Respir J 1996; 9: 992–999.
29 Borregaard N, Cowland JB. Granules of the human neutrophilic
polymorphonuclear leukocyte. Blood 1997; 89: 3503–3521.
30 Schmekel B, Karlsson SE, Linden M, et al. Myeloperoxidase in
human lung lavage. I. A marker of local neutrophil activity.
Inflammation 1990; 14: 447–454.
31 Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA-antigens
stimulates superoxide release by human neutrophils. J Am Soc
Nephrol 1997; 8: 386–394.
32 Lynch JP III, Standiford TJ, Rolfe MW, et al. Neutrophilic alveolitis
in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev
Respir Dis 1992; 145: 1433–1439.
33 Miller EJ, Cohen AB, Nagao S, et al. Elevated levels of NAP-1/
interleukin-8 are present in the airspaces of patients with the adult
respiratory distress syndrome and are associated with increased
mortality. Am Rev Respir Dis 1992; 146: 427–432.
34 Ralston DR, Marsh CB, Lowe MP, et al. Antineutrophil cytoplasmic
antibodies induce monocyte IL-8 release. Role of surface proteinase-3, a1-antitrypsin, and Fcc receptors. J Clin Invest 1997;
100: 1416–1424.
35 Csernok E, Ernst M, Schmitt W, et al. Activated neutrophils
express proteinase 3 on their plasma membrane in vitro and in
vivo. Clin Exp Immunol 1994; 95: 244–250.
36 Zhou Z, Richard C, Menard HA. De novo synthesis of proteinase 3
by cytokine primed circulating human polymorphonuclear neutrophils
and mononuclear cells. J Rheumatol 2000; 27: 2406–2411.
37 Loetscher P, Seitz M, Clark-Lewis I, et al. Both interleukin-8 receptors
independently mediate chemotaxis. Jurkat cells transfected with
IL-8R1 or IL-8R2 migrate in response to IL-8, GRO-a and NAP-2.
FEBS Lett 1994; 341: 187–192.
38 Hebert CA, Baker JB. Interleukin-8: a review. Cancer Invest 1993;
11: 743–750.
39 Liu L, Mul FP, Kuijpers TW, et al. Neutrophil transmigration across
monolayers of endothelial cells and airway epithelial cells is
regulated by differentmechanisms. Ann NY Acad Sci 1996; 796: 21–29.
40 Pease JE, Sabroe I. The role of interleukin-8 and its receptors in
inflammatory lung disease: implications for therapy. Am J Respir
Med 2002; 1: 19–25.